Clinical studies on POSTN expression have shown that elevated levels of serum POSTN or tissue POSTN are associated with the increased malignant behavior of multiple types of cancer, such as melanomas [1], lung metastases [2], and colon [3], pancreatic [4], esophageal [5], and ovarian [6] cancers. This evidence concerns the gene POSTN and cancer.